Is Jazz Pharmaceuticals (JAZZ) Offering Value After Recent Pullback And 32.7% One Year Gain
If you are wondering whether Jazz Pharmaceuticals is offering good value at around US$161.13 per share, this article walks through
Read MoreIf you are wondering whether Jazz Pharmaceuticals is offering good value at around US$161.13 per share, this article walks through
Read MoreLewes, Delaware, Jan. 10, 2026 (GLOBE NEWSWIRE) — The Global Pharmaceutical Waste Management Market Size is projected to grow at a
Read MoreJust before Christmas 2025, the US Centers for Medicare and Medicaid Services (CMS) unveiled two pricing models based on the
Read MorePharmTech recently spoke with Mike Stenberg, Vice President – Business Development, LGM Pharma, to get his perspective on trends that
Read MoreGrowing up in Agartala, India, Bodhi Chaudhuri moved to the United States after receiving his Bachelor of Chemical Engineering from Jadavpur University, Kolkata, and his
Read MoreThe pharmaceutical industry experienced a complicated 2025, with challenges arising in a variety of areas including supply chain security and
Read Moreby Mary Spiller January 4, 2026 New analysis shows medication costs continuing to rise even as drugmakers agree to Trump
Read MoreThe impending patent expiry of semaglutide drugs across India, emerging markets and select regulated markets such as Canada and Brazil
Read MoreMexico’s pharmaceutical industry continues to consolidate its role as a driver of economic activity, employment, and healthcare access, while adapting
Read MoreThese two companies have very different risk-reward profiles. Recursion Pharmaceuticals (RXRX 0.49%), a small-cap biotech company, has one claim to
Read More